EP0892639A4 - PROCEDE DE TRAITEMENT DES CONTRACTIONS UTERINES INDESIRABLES PAR UTILISATION D'ISOMERES R OU RR OPTIQUEMENT PURS D'AGONISTES -g(b)-2 ADRENERGIQUES - Google Patents

PROCEDE DE TRAITEMENT DES CONTRACTIONS UTERINES INDESIRABLES PAR UTILISATION D'ISOMERES R OU RR OPTIQUEMENT PURS D'AGONISTES -g(b)-2 ADRENERGIQUES

Info

Publication number
EP0892639A4
EP0892639A4 EP97905640A EP97905640A EP0892639A4 EP 0892639 A4 EP0892639 A4 EP 0892639A4 EP 97905640 A EP97905640 A EP 97905640A EP 97905640 A EP97905640 A EP 97905640A EP 0892639 A4 EP0892639 A4 EP 0892639A4
Authority
EP
European Patent Office
Prior art keywords
agonists
isomers
optically pure
uterine contractions
adrenergic beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP97905640A
Other languages
German (de)
English (en)
Other versions
EP0892639A1 (fr
Inventor
E Charles Pesterfield Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAVOR EVELYN
Original Assignee
SAVOR EVELYN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/592,988 external-priority patent/US5708036A/en
Application filed by SAVOR EVELYN filed Critical SAVOR EVELYN
Publication of EP0892639A1 publication Critical patent/EP0892639A1/fr
Publication of EP0892639A4 publication Critical patent/EP0892639A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP97905640A 1996-01-29 1997-01-28 PROCEDE DE TRAITEMENT DES CONTRACTIONS UTERINES INDESIRABLES PAR UTILISATION D'ISOMERES R OU RR OPTIQUEMENT PURS D'AGONISTES -g(b)-2 ADRENERGIQUES Ceased EP0892639A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US592988 1996-01-29
US08/592,988 US5708036A (en) 1996-01-29 1996-01-29 Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
US2299596P 1996-08-02 1996-08-02
US22995P 1996-08-02
PCT/US1997/001342 WO1997026871A1 (fr) 1996-01-29 1997-01-28 PROCEDE DE TRAITEMENT DES CONTRACTIONS UTERINES INDESIRABLES PAR UTILISATION D'ISOMERES R OU RR OPTIQUEMENT PURS D'AGONISTES β-2 ADRENERGIQUES

Publications (2)

Publication Number Publication Date
EP0892639A1 EP0892639A1 (fr) 1999-01-27
EP0892639A4 true EP0892639A4 (fr) 1999-06-09

Family

ID=26696599

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97905640A Ceased EP0892639A4 (fr) 1996-01-29 1997-01-28 PROCEDE DE TRAITEMENT DES CONTRACTIONS UTERINES INDESIRABLES PAR UTILISATION D'ISOMERES R OU RR OPTIQUEMENT PURS D'AGONISTES -g(b)-2 ADRENERGIQUES

Country Status (4)

Country Link
EP (1) EP0892639A4 (fr)
AU (1) AU2247997A (fr)
CA (1) CA2247953A1 (fr)
WO (1) WO1997026871A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ500250A (en) * 1997-04-30 2001-03-30 Bridge Pharma Inc Adrenergic beta-2 agonist eutomers, feed compositions and use for increasing muscle and decreasing fat
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
CA2427388C (fr) 2000-11-01 2011-12-20 Sention, Inc. Compositions pharmaceutiques et leurs utilisations pour ameliorer les troubles de la memoire et de l'apprentissage
US20030232890A1 (en) 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
US7619005B2 (en) 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20120028906A1 (en) * 2009-03-13 2012-02-02 Loma Linda University Method for affecting the timing of cervical ripening and for parturition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (fr) * 1980-07-09 1982-01-13 Aktiebolaget Draco Dérivés du 1-(dihydroxyphényl)-2-amino éthanol; préparation, compositions et intermédiaires
EP0455155A1 (fr) * 1990-05-04 1991-11-06 Boehringer Ingelheim Vetmedica Gmbh Séparation des énantiomères de cimatérol
WO1992016173A1 (fr) * 1991-03-19 1992-10-01 Sepracor, Inc. Procedes et compositions de traitement de troubles pulmonaires utilisant de la terbutaline optiquement pure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69009946T2 (de) * 1989-12-04 1994-11-03 Searle & Co System zur transdermalen Albuterol Applikation.
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
US5370135A (en) * 1993-10-13 1994-12-06 Biex, Inc. Use of estriol measurement to monitor tocolytic therapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (fr) * 1980-07-09 1982-01-13 Aktiebolaget Draco Dérivés du 1-(dihydroxyphényl)-2-amino éthanol; préparation, compositions et intermédiaires
EP0455155A1 (fr) * 1990-05-04 1991-11-06 Boehringer Ingelheim Vetmedica Gmbh Séparation des énantiomères de cimatérol
WO1992016173A1 (fr) * 1991-03-19 1992-10-01 Sepracor, Inc. Procedes et compositions de traitement de troubles pulmonaires utilisant de la terbutaline optiquement pure

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BORGSTRÖM L. ET AL: "Relative absorption of the two enantiomers of terbutaline after duodenal administration", EUR. J. CLIN. PHARMACOL., vol. 38, no. 6, 1990, pages 621 - 624, XP002097503 *
See also references of WO9726871A1 *

Also Published As

Publication number Publication date
EP0892639A1 (fr) 1999-01-27
AU2247997A (en) 1997-08-20
CA2247953A1 (fr) 1997-07-31
WO1997026871A1 (fr) 1997-07-31

Similar Documents

Publication Publication Date Title
AU2543097A (en) Method for treating pain
IL139336A0 (en) Method of selective photothermolysis
AU4094197A (en) Selective beta3 adrenergic agonists
HUP9902770A3 (en) Modulators of tissue regeneration
ZA9711437B (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
CZ176399A3 (cs) Rozhraní širokopásmového telekomunikačního systému
PL336998A1 (en) Method of improving quality of hydrocarbons
GB2332284B (en) Branched optical waveguide,and its method of use
PL334495A1 (en) Method of treating lupiform nephritis using substances acting against cd40l
AU4808997A (en) Methods and compounds for treatment of abnormal uterine bleeding
EP0706131A3 (fr) Procédé et système d'attribution efficace de lignes d'antémémoire au cours de séquence de ratage d'antémémoire
GB9520615D0 (en) Method of preventing bone loss
GB2294179B (en) Method of and system for use of telecommunication networks
HUP9902451A3 (en) Process and device for promotion of regeneration of organized tissues
EP0892639A4 (fr) PROCEDE DE TRAITEMENT DES CONTRACTIONS UTERINES INDESIRABLES PAR UTILISATION D'ISOMERES R OU RR OPTIQUEMENT PURS D'AGONISTES -g(b)-2 ADRENERGIQUES
PL333370A1 (en) Method of using cyclo-oxygenase-2 inhibitors as agents acting against overgrowth of vessels
EP0680020A3 (fr) Appareil et procédé pour le calcul direct de coordonnées d'une région de découpage.
HU228271B1 (en) Compositions for treating soils, method of preparation and use thereof
IL126063A0 (en) Method for treating migraine pain
ZA974421B (en) Method of improving skin condition.
ZA972628B (en) Process for passivating surgical needles
AU4408897A (en) Method of treating retinal ischemia and glaucoma, using optically pure r- or rr- isomers of adrenergic beta-2 agonists
AU9672598A (en) Galenic forms of r-or rr-isomers of adrenergic beta-2 agonists
PL324172A1 (en) Malatonin agonists for treating mild forms of prostatic hypertrophy
PL331383A1 (en) Catalyst, itsa application and method of obtaining same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980828

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990428

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 6A 61K 31/195 A, 6A 61K 31/135 B

17Q First examination report despatched

Effective date: 20020405

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20050505